These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 31986409)

  • 1. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis.
    Zheng F; Xu R
    Biomed Pharmacother; 2020 Apr; 124():109828. PubMed ID: 31986409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis.
    Cao L; Zhou X; Ding X; Gao D
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma.
    Mao Y; Xu R
    Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting
    Wang Z; Pan L; Yu H; Wang Y
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29592872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis to activate WNT pathway.
    Wei Y; Wei L; Li J; Ma Z; Zhang Q; Han Z; Li S
    Cancer Med; 2020 Oct; 9(19):7205-7217. PubMed ID: 32762035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
    Seidl C; Panzitt K; Bertsch A; Brcic L; Schein S; Mack M; Leithner K; Prinz F; Olschewski H; Kornmueller K; Hrzenjak A
    Cancer Lett; 2020 Jan; 469():266-276. PubMed ID: 31697978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.
    Li J; Li S; Chen Z; Wang J; Chen Y; Xu Z; Jin M; Yu W
    Tumour Biol; 2016 Oct; 37(10):13287-13294. PubMed ID: 27460077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1.
    Pei K; Zhu JJ; Wang CE; Xie QL; Guo JY
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4697-4704. PubMed ID: 27906433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
    Pan X; Chen Y; Shen Y; Tantai J
    Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-195-5p inhibits cisplatin resistance in lung adenocarcinoma by regulating DNA damage via targeting E2F7.
    Wu H; Zheng B
    J Biochem Mol Toxicol; 2024 Nov; 38(11):e70015. PubMed ID: 39415701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGD5‑AS1 promotes cisplatin resistance of human lung adenocarcinoma cell via the miR‑142‑5p/PD‑L1 axis.
    Zhu F; Niu R; Shao X; Shao X
    Int J Mol Med; 2021 Feb; 47(2):523-532. PubMed ID: 33416094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NORAD/miR-202-5p regulates the drug resistance of A549/DDP to cisplatin by targeting P-gp.
    Shen JG; Xu SN; Yin LG
    Gen Physiol Biophys; 2020 Sep; 39(5):481-489. PubMed ID: 33084601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA-NEAT1 facilitates autophagy to boost pemetrexed resistance in lung adenocarcinoma via the mir-379-3p/HIF1A pathway.
    Hu W; Cao W; Liu J
    Hum Exp Toxicol; 2024; 43():9603271241292169. PubMed ID: 39397480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-21-5p knockdown inhibits epithelial to mesenchymal transition in A549 lung adenocarcinoma cells by upregulating RhoB.
    Khair HHA; Karagöz ID
    Mol Biol Rep; 2024 Jul; 51(1):837. PubMed ID: 39042337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
    Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
    Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circPVT1 Contributes to Doxorubicin (DXR) Resistance of Osteosarcoma Cells by Regulating TRIAP1 via miR-137.
    Li D; Huang Y; Wang G
    Biomed Res Int; 2021; 2021():7463867. PubMed ID: 33981772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
    Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J
    Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer.
    Liu L; Zhang Q; Peng H
    J Chemother; 2023 Feb; 35(1):39-52. PubMed ID: 35289739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma.
    Chen J; Jiang F; Hu L; Zhang F; Wang J; Huang K; Wang Y
    Biomed Res Int; 2020; 2020():2806042. PubMed ID: 32626737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.